LiDCO Group Plc (AIM:LID), the UK-based hemodynamic monitoring company, today announces that it has signed an agreement with ICU Medical, Inc. of San Clemente, California, USA ("ICU† Medical") appointing LiDCO as a non exclusive distributor of† complementary ICU Medical products in the UK. This will add to the third party products that LiDCO can offer to its UK customers.
In addition the two companies signed a non exclusive licensing agreement providing ICU Medical access to some of LiDCO's intellectual property (IP) rights. †Under the terms of the agreement, LiDCO will receive an up front payment and royalties on any future sales derived from the IP.
ICU Medical develops, manufacturers and sells innovative medical technologies used by hospitals in acute care settings.
Dr Terry O'Brien, CEO of LiDCO stated "We are delighted to sign this agreement with ICU Medical. These arrangements will complement our third party offering to customers in the UK and adds to our growing base of corporate partners."
For further information, please contact:
LiDCO Group Plc
Terry O'Brien (CEO)
Tel: +44 (0)20 7749 1500
Paul Clifford (Finance Director)
John Rowland (Company Secretary)††††††††††††††††††††††††††††††††††††††††
LiDCO is a supplier of minimally invasive hemodynamic equipment to hospitals, to monitor the amount of blood flowing around the body and ensure that vital organs are adequately oxygenated. LiDCO's products facilitate the application of hemodynamic optimization protocols for high risk patients in both critical care units and in the operating theatre.
This information is provided by RNS
The company news service from the London Stock Exchange
Datafeed and UK data supplied by NETbuilder and Interactive Data.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk!
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.